These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3203124)

  • 1. Neonatal and adult copper-64 metabolism in the pig and the possible relationship between the ontogeny of copper metabolism and Wilson's disease.
    Bingle CD; Srai SK; Whiteley GS; Epstein O
    Biol Neonate; 1988; 54(5):294-300. PubMed ID: 3203124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ontogeny of liver copper metabolism in the guinea pig: clues to the etiology of Wilson's disease.
    Srai SK; Burroughs AK; Wood B; Epstein O
    Hepatology; 1986; 6(3):427-32. PubMed ID: 3710431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes in hepatic copper proteins in the guinea pig.
    Bingle CD; Srai SK; Epstein O
    J Hepatol; 1990 Mar; 10(2):138-43. PubMed ID: 2332582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease.
    LaRusso NF; Summerskill WH; McCall JT
    Gastroenterology; 1976 May; 70(5 PT.1):653-5. PubMed ID: 1261757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper metabolism in hypercupremic human livers. Studies of its subcellular distribution, association with binding proteins and expression of mRNAs.
    Bingle CD; Srai SK; Epstein O
    J Hepatol; 1992 May; 15(1-2):94-101. PubMed ID: 1506662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.
    Williams AO
    Br J Exp Pathol; 1965 Oct; 46(5):564-8. PubMed ID: 5838405
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
    Graul RS; Epstein O; Sherlock S; Scheuer PJ
    Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is copper incorporation to caeruloplasmin normal in Wilson's disease?
    Chowrimootoo GF; Seymour CA
    Biochem Soc Trans; 1994 May; 22(2):191S. PubMed ID: 7958254
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies with radioactive copper ( 64 Cu and 67 Cu); the incorporation of radioactive copper into caeruloplasmin in Wilson's disease and in primary biliary cirrhosis.
    Gibbs K; Walshe JM
    Clin Sci; 1971 Sep; 41(3):189-202. PubMed ID: 5571499
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans.
    Su LC; Ravanshad S; Owen CA; McCall JT; Zollman PE; Hardy RM
    Am J Physiol; 1982 Sep; 243(3):G226-30. PubMed ID: 7114265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low content of hepatic reduced glutathione in patients with Wilson's disease.
    Summer KH; Eisenburg J
    Biochem Med; 1985 Aug; 34(1):107-11. PubMed ID: 4052057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal copper metabolism: another "non-Wilson's" case.
    Heckmann J; Saffer D
    Neurology; 1988 Sep; 38(9):1493-5. PubMed ID: 3274209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Copper pathology (author's transl)].
    Mallet B; Romette J; Di Costanzo JD
    Nouv Presse Med; 1982 Jan; 11(4):271-4. PubMed ID: 7058150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 20. Copper kinetics in liver disease.
    Smallwood RA; McIlveen B; Rosenoer VM; Sherlock S
    Gut; 1971 Feb; 12(2):139-44. PubMed ID: 5548560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.